Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PY314 |
Trade Name | |
Synonyms | PY-314|PY 314 |
Drug Descriptions |
PY314 is a monoclonal antibody that targets TREM2 expressed on tumor-associated macrophages (TAMs), potentially resulting in depletion of M2-like TAMs, activation of the immune response, and anti-tumor activity (Mol Cancer Ther 2019;18(12 Suppl):Abstract nr C104). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C179597 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + PY314 | PY314 Pembrolizumab | 0 | 1 |
PY314 | PY314 | 0 | 1 |